Amyloid β-Protein (Human, 1-28)
Référence 4481-v
Conditionnement : 0.5mg
Marque : Peptide Institute
Contactez votre distributeur local :
Téléphone : +1 850 650 7790
Amyloid β-Protein (Human, 1-28)
- Code:
- 4481-v
- Name:
- Amyloid β-Protein (Human, 1-28)
- SP-28 (Human)
- Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys
- (Trifluoroacetate Form)
- (M.W. 3262.5) C145H209N41O46
- Amyloidogenic Segment of Amyloid β-Protein
- Purity:
- ≧99.0% (HPLC)
- Storage:
- -20 ℃
- Source:
- Human
Solubility: H2O (0.1 mM)
- Category:
- Biologically Active Peptides
reference
- D.A. Kirschner, H. Inouye, L.K. Duffy, A. Sinclair, M. Lind, and D.J. Selkoe, Proc. Natl. Acad. Sci. U.S.A., 84, 6953 (1987). (Original; Amyloid-Like Fibril Formation)
- B. Klajnert, M. Cortijo-Arellano, J. Cladera, and M. Bryszewska, Biochem. Biophys. Res. Commun., 345, 21 (2006). (Amyloid Fibril Formation)
- A. Perálvarez-Marin, A. Barth, and A. Gräslund, J. Mol. Biol., 379, 589 (2008). (Amyloid Fibril Formation)
- N.G.N. Milton and J.R. Harris, Micron, 40, 800 (2009). (Amyloid Fibril Formation)
- T. Wasiak, M. Ionov, K. Nieznanski, H. Nieznanska, O. Klementieva, M. Granell, J. Cladera, J.-P. Majoral, A.M. Caminade, and B. Klajnert, Mol. Pharm., 9, 458 (2012). (Amyloid Fibril Formation & Neurotoxity)
- J.S. Whitson, D.J. Selkoe, and C.W. Cotman, Science, 243, 1488 (1989). (Pharmacol.)
- B.A. Yankner, L.K. Duffy, and D.A. Kirschner, Science, 250, 279 (1990). (Pharmacol.)